葡京会员开户

About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

High Dosage Strength for Rivastigmine Once-A-Day Transdermal Patch Receives Market Authorization in Germany——Luye Pharma’s CNS Portfolio ...

News

Luye Pharma Group has announced that the German Federal Institute for Drugs and Medical Devices has approved the marketing authorization of the company’s Rivastigmine once-a-day transdermal patch in a dosage of 13.3mg/24h. The high dosage ...

July 15,2019

Luye Pharma’s Acarbose Capsules (Beixi) Passes NMPA’s Generic Drug Quality Consistency Evaluation

Luye Pharma has announced that one of its core anti-diabetic drugs, Acarbose Capsules (Brand Name: Beixi), has passed the Generic Drug Quality Consistency Evaluation (GQCE) conducted by China's National Medicinal Products Administration ...

June 03,2019

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company